Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

838 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges.
Working Group on the Summit on Combination Therapy for CVD; Yusuf S, Attaran A, Bosch J, Joseph P, Lonn E, McCready T, Mente A, Nieuwlaat R, Pais P, Rodgers A, Schwalm JD, Smith R, Teo K, Xavier D. Working Group on the Summit on Combination Therapy for CVD, et al. Among authors: rodgers a. Eur Heart J. 2014 Feb;35(6):353-64. doi: 10.1093/eurheartj/eht407. Epub 2013 Nov 27. Eur Heart J. 2014. PMID: 24288261 Review.
Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data.
Karmali KN, Lloyd-Jones DM, van der Leeuw J, Goff DC Jr, Yusuf S, Zanchetti A, Glasziou P, Jackson R, Woodward M, Rodgers A, Neal BC, Berge E, Teo K, Davis BR, Chalmers J, Pepine C, Rahimi K, Sundström J; Blood Pressure Lowering Treatment Trialists’ Collaboration. Karmali KN, et al. Among authors: rodgers a. PLoS Med. 2018 Mar 20;15(3):e1002538. doi: 10.1371/journal.pmed.1002538. eCollection 2018 Mar. PLoS Med. 2018. PMID: 29558462 Free PMC article.
Effects of blood pressure lowering on cardiovascular events, in the context of regression to the mean: a systematic review of randomized trials.
Salam A, Atkins E, Sundström J, Hirakawa Y, Ettehad D, Emdin C, Neal B, Woodward M, Chalmers J, Berge E, Yusuf S, Rahimi K, Rodgers A; Blood Pressure Lowering Treatment Trialists’ Collaboration. Salam A, et al. Among authors: rodgers a. J Hypertens. 2019 Jan;37(1):16-23. doi: 10.1097/HJH.0000000000001994. J Hypertens. 2019. PMID: 30499920 Free article.
Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis.
Blood Pressure Lowering Treatment Trialists' Collaboration. Blood Pressure Lowering Treatment Trialists' Collaboration. Lancet. 2021 Sep 18;398(10305):1053-1064. doi: 10.1016/S0140-6736(21)01921-8. Epub 2021 Aug 27. Lancet. 2021. PMID: 34461040 Free PMC article.
Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis.
Joseph P, Roshandel G, Gao P, Pais P, Lonn E, Xavier D, Avezum A, Zhu J, Liu L, Sliwa K, Gamra H, Bangdiwala SI, Teo K, Diaz R, Dans A, Lopez-Jaramillo P, Prabhakaran D, Castellano JM, Fuster V, Rodgers A, Huffman MD, Bosch J, Dagenais GR, Malekzadeh R, Yusuf S; Polypill Trialists' Collaboration. Joseph P, et al. Among authors: rodgers a. Lancet. 2021 Sep 25;398(10306):1133-1146. doi: 10.1016/S0140-6736(21)01827-4. Epub 2021 Aug 29. Lancet. 2021. PMID: 34469765
Prospective meta-analysis of trials comparing fixed dose combination based care with usual care in individuals at high cardiovascular risk: the SPACE Collaboration.
Webster R, Patel A, Billot L, Cass A, Burch C, Neal B, Usherwood T, Thom S, Poulter N, Stanton A, Bots ML, Grobbee DE, Prabhakaran D, Reddy KS, Field J, Bullen C, Elley CR, Selak V, Rafter N, Wadham A, Berwanger O, Rodgers A; SPACE Collaboration. Webster R, et al. Among authors: rodgers a. Int J Cardiol. 2013 Dec 5;170(1):30-5. doi: 10.1016/j.ijcard.2013.10.007. Epub 2013 Oct 12. Int J Cardiol. 2013. PMID: 24144927
838 results